$VCEL
Vericel Corp Stock $vcel

$vcel Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-K Financial Statement

#000162828016012668 Filed on March 14, 2016

Income Statement

Concept	2016 Q1	2014 Q4	2014 Q3
Revenue	$14.11M	$14.71M	$9.658M
YoY Change	30.04%	146960.0%
Cost Of Revenue	$6.560M	$6.650M	$5.532M
YoY Change	17.82%
Gross Profit	$7.548M	$7.954M	$4.126M
YoY Change	42.93%	79440.0%
Gross Profit Margin	53.5%	54.09%	42.72%
Selling, General & Admin	$6.004M	$4.010M	$4.313M
YoY Change	9.64%	147.53%	304.6%
% of Gross Profit	79.54%	50.41%	104.53%
Research & Development	$3.536M	$5.790M	$7.835M
YoY Change	-19.21%	74.4%	204.27%
% of Gross Profit	46.85%	72.79%	189.89%
Depreciation & Amortization	$445.0K	$250.0K	$200.0K
YoY Change	35.67%	150.0%	81.82%
% of Gross Profit	5.9%	3.14%	4.85%
Operating Expenses	$9.540M	$9.800M	$12.15M
YoY Change	-3.18%	98.78%	233.64%
Operating Profit	-$1.992M	-$2.345M	-$8.022M
YoY Change	-56.43%	-52.34%	120.32%
Interest Expense	$3.000K	$140.0K	$1.000K
YoY Change	50.0%	-93.03%	-66.67%
% of Operating Profit
Other Income/Expense, Net	-$1.658M	-$160.0K	$1.105M
YoY Change	471.72%		-19.23%
Pretax Income	-$3.650M	-$2.370M	-$6.920M
YoY Change	-24.9%	-18.84%	204.85%
Income Tax
% Of Pretax Income
Net Earnings	-$3.650M	-$2.370M	-$6.917M
YoY Change	-24.93%	-18.84%	204.31%
Net Earnings / Revenue	-25.87%	-16.12%	-71.62%
Basic Earnings Per Share
Diluted Earnings Per Share	-$161.5K	-$99.33K	-$673.8K
COMMON SHARES
Basic Shares Outstanding	23.85M shares		8.001M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.50M	$30.30M	$37.60M
YoY Change	-47.88%	274.07%	248.15%
Cash & Equivalents	$13.50M	$30.30M	$37.60M
Short-Term Investments
Other Short-Term Assets	$662.0K	$1.036M	$1.500M
YoY Change	-21.66%	153.3%	175.23%
Inventory	$1.942M	$1.920M	$1.700M
Prepaid Expenses
Receivables	$9.669M	$8.191M	$4.000M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.82M	$41.49M	$44.70M
YoY Change	-31.92%	389.5%	293.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.393M	$2.892M	$2.400M
YoY Change	27.48%	291.34%	185.37%
Goodwill
YoY Change
Intangibles	$2.847M	$3.197M
YoY Change	-8.95%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$7.240M	$6.089M	$5.700M
YoY Change	10.15%	723.95%	577.76%
TOTAL ASSETS
Total Short-Term Assets	$25.82M	$41.49M	$44.70M
Total Long-Term Assets	$7.240M	$6.089M	$5.700M
Total Assets	$33.06M	$47.58M	$50.40M
YoY Change	-25.7%	416.32%	313.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.293M	$5.824M	$2.500M
YoY Change	-6.44%	147.3%	-13.79%
Accrued Expenses	$16.00K	$4.714M	$3.100M
YoY Change	-89.61%	1503.4%	933.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$13.77M	$11.83M	$12.50M
YoY Change	9.07%	122.31%	72.37%
LONG-TERM LIABILITIES
Long-Term Debt	$62.00K	$109.0K	$100.0K
YoY Change	-38.0%
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$62.00K	$109.0K	$100.0K
YoY Change	-62.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.77M	$11.83M	$12.50M
Total Long-Term Liabilities	$62.00K	$109.0K	$100.0K
Total Liabilities	$13.83M	$11.94M	$12.60M
YoY Change	8.14%	124.36%	73.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$327.7M
YoY Change
Common Stock	$308.5M	$305.0M
YoY Change	0.84%	20.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.150M	$0.00
YoY Change
Treasury Stock Shares		1.250M shares
Shareholders Equity	$19.23M	$35.64M	$37.80M
YoY Change
Total Liabilities & Shareholders Equity	$33.06M	$47.58M	$50.40M
YoY Change	-25.7%	416.32%	313.05%

Cashflow Statement

Concept	2016 Q1	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	-$3.650M	-$2.370M	-$6.917M
YoY Change	-24.93%	-18.84%	204.31%
Depreciation, Depletion And Amortization	$445.0K	$250.0K	$200.0K
YoY Change	35.67%	150.0%	81.82%
Cash From Operating Activities	-$1.270M	-$6.240M	-$8.430M
YoY Change	-69.1%	43.78%	103.62%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$750.0K	-$70.00K
YoY Change	-97.14%
Acquisitions	$13.00K
YoY Change	-96.32%
Other Investing Activities	-$93.00K	$100.0K	-$2.500M
YoY Change	165.71%
Cash From Investing Activities	$80.00K	-$650.0K	-$2.570M
YoY Change	-125.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$37.50M
YoY Change			357.32%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	150.0K	-300.0K	41.32M
YoY Change	-1600.0%	-118.99%	295.03%
NET CHANGE
Cash From Operating Activities	-1.270M	-6.240M	-8.430M
Cash From Investing Activities	80.00K	-650.0K	-2.570M
Cash From Financing Activities	150.0K	-300.0K	41.32M
Net Change In Cash	-1.040M	-7.190M	30.32M
YoY Change	-76.58%	160.51%	379.75%
FREE CASH FLOW
Cash From Operating Activities	-$1.270M	-$6.240M	-$8.430M
Capital Expenditures	-$10.00K	-$750.0K	-$70.00K
Free Cash Flow	-$1.260M	-$5.490M	-$8.360M
YoY Change	-66.49%	26.5%	101.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	astm	Accrued Expenses Current AccruedExpensesCurrent	605000	USD
CY2015Q4	astm	Accrued Expenses Current AccruedExpensesCurrent	75000	USD
CY2014Q4	astm	Accrued Expenses Other Current AccruedExpensesOtherCurrent	436000	USD
CY2015Q4	astm	Accrued Expenses Other Current AccruedExpensesOtherCurrent	231000	USD
CY2011Q3	astm	Class Of Warrant Or Right Additional Number Of Rights Distributed Per Common Share ClassOfWarrantOrRightAdditionalNumberOfRightsDistributedPerCommonShare	1	right
CY2013Q4	astm	Class Of Warrant Or Right Number Of Rights Deemed To Be Delivered Per Common Stock Share Issued Or Transferred ClassOfWarrantOrRightNumberOfRightsDeemedToBeDeliveredPerCommonStockShareIssuedOrTransferred	20	right
CY2011Q3	astm	Class Of Warrant Or Right Number Of Rights Per Common Stock Share ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare	1	right
CY2013Q4	astm	Class Of Warrant Or Right Number Of Rights Per Common Stock Share ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare	20	right
CY2015Q4	astm	Convertible Preferred Stock Maximum Beneficial Ownership Percentage ConvertiblePreferredStockMaximumBeneficialOwnershipPercentage	0.0999
CY2015Q4	astm	Convertible Preferred Stock Maximum Beneficial Ownership Percentage Upon Holders Election ConvertiblePreferredStockMaximumBeneficialOwnershipPercentageUponHoldersElection	0.1499
CY2014Q4	astm	Deferred Tax Assets Research And Development Costs DeferredTaxAssetsResearchAndDevelopmentCosts	2184000	USD
CY2015Q4	astm	Deferred Tax Assets Research And Development Costs DeferredTaxAssetsResearchAndDevelopmentCosts	4903000	USD
CY2013	astm	Income Tax Reconciliation Limitations On Net Operating Loss IncomeTaxReconciliationLimitationsOnNetOperatingLoss	0	USD
CY2014	astm	Income Tax Reconciliation Limitations On Net Operating Loss IncomeTaxReconciliationLimitationsOnNetOperatingLoss	-67781000	USD
CY2015	astm	Income Tax Reconciliation Limitations On Net Operating Loss IncomeTaxReconciliationLimitationsOnNetOperatingLoss	0	USD
CY2013	astm	Income Tax Reconciliation Net Operating Loss Benefit IncomeTaxReconciliationNetOperatingLossBenefit	791000	USD
CY2014	astm	Income Tax Reconciliation Net Operating Loss Benefit IncomeTaxReconciliationNetOperatingLossBenefit	0	USD
CY2015	astm	Income Tax Reconciliation Net Operating Loss Benefit IncomeTaxReconciliationNetOperatingLossBenefit	0	USD
CY2013	astm	Income Tax Reconciliation Net Operating Loss Expirations IncomeTaxReconciliationNetOperatingLossExpirations	612000	USD
CY2014	astm	Income Tax Reconciliation Net Operating Loss Expirations IncomeTaxReconciliationNetOperatingLossExpirations	655000	USD
CY2015	astm	Income Tax Reconciliation Net Operating Loss Expirations IncomeTaxReconciliationNetOperatingLossExpirations	0	USD
CY2013	astm	Income Tax Reconciliation Warrants IncomeTaxReconciliationWarrants	-1815000	USD
CY2014	astm	Income Tax Reconciliation Warrants IncomeTaxReconciliationWarrants	-10000	USD
CY2015	astm	Income Tax Reconciliation Warrants IncomeTaxReconciliationWarrants	-118000	USD
CY2015	astm	Netunrealizedbuiltin Gain NetunrealizedbuiltinGain	8900000	USD
CY2014Q3	astm	Operating Loss Carryforwards Limitations On Use Projected Annual Limitation On Use Of Net Operating Losses OperatingLossCarryforwardsLimitationsOnUseProjectedAnnualLimitationOnUseOfNetOperatingLosses	800000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDue	28111000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Current OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueCurrent	4653000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Four Years OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInFourYears	4260000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Three Years OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInThreeYears	4604000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Two Years OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInTwoYears	4933000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Thereafter OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueThereafter	5275000	USD
CY2015Q4	astm	Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Duein Five Years OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueinFiveYears	4386000	USD
CY2014Q3	astm	Period Over Which Cumulative Change Of Ownership Required For Change In Control PeriodOverWhichCumulativeChangeOfOwnershipRequiredForChangeInControl	P3Y
CY2015	astm	Preferred Stock Cumulative Dividend Rate Percentage PreferredStockCumulativeDividendRatePercentage	0.115
CY2014Q3	astm	Underwriters Discount UnderwritersDiscount	2400000	USD
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000887359
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23852412	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	86924377	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	Vericel Corp
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5824000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7588000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8191000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10919000	USD
CY2014Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2044000	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1956000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4714000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3603000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4397000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5638000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-71000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	839000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2747000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	980000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3167000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	68000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2400000	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2300000	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6700000	shares
CY2014Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	348000	USD
CY2015Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0	USD
CY2013	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	0	USD
CY2014	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	-1102000	USD
CY2015	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	-268000	USD
CY2014Q4	us-gaap	Assets Assets	47579000	USD
CY2015Q4	us-gaap	Assets Assets	34309000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	41490000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	27343000	USD
CY2013	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2014	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	3473000	USD
CY2015	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	199000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	42000	USD
CY2013	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	153000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	118000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	43000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	32000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	43000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2012Q4	us-gaap	Cash Cash	13638000	USD
CY2015Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2013Q4	us-gaap	Cash Cash	8059000	USD
CY2014Q4	us-gaap	Cash Cash	30343000	USD
CY2015Q4	us-gaap	Cash Cash	14581000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23786000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23789000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23786000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23789000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	305008000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	307766000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15622000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19991000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16269000	USD
CY2014	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2490000	USD
CY2015	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	11000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	17293000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	26470000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-510000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-477000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11345000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22015000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	186000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	510000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7092000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13998000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	115000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	143000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	254000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	453000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1897000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2485000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations	127000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11345000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22015000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	500000	USD
CY2015	us-gaap	Depreciation Depreciation	1300000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	489000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	752000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	800000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1592000	USD
CY2014Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	307685000	USD
CY2015Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	324025000	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.95
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.26
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.94
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.82
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.23
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-54000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1281000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1341000	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5337000	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	27000	USD
CY2015	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-324000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1517000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	280000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	280000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	280000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	280000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	280000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2917000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	152000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-67000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-139000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	35000	USD
CY2013	us-gaap	Gross Profit GrossProfit	15000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	-577000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	4126000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	7954000	USD
CY2014	us-gaap	Gross Profit GrossProfit	11503000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	5281000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	6689000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	4537000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	8191000	USD
CY2015	us-gaap	Gross Profit GrossProfit	24698000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15622000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19920000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16340000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7251000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-63190000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10669000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5311000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6773000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5556000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	81000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	48000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	543000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-27000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	352000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	57000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-463000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-392000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-1600000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-571000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2773000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1726000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	237000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3007000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-764000	USD
CY2013	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	0	USD
CY2014	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	0	USD
CY2015	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	-80000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-119000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	86000	USD
CY2013	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	65000	USD
CY2014	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	455000	USD
CY2015	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-572000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	175000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-52000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	0	USD
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	8139000	USD
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2728000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3197000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2917000	USD
CY2013	us-gaap	Interest Expense InterestExpense	11000	USD
CY2014	us-gaap	Interest Expense InterestExpense	6000	USD
CY2015	us-gaap	Interest Expense InterestExpense	9000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	384000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	1920000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1379000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1078000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1228000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	458000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	131000	USD
CY2013	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015	us-gaap	Inventory Write Down InventoryWriteDown	627000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	16000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	24000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	36000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	11938000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	12179000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47579000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34309000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11829000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12108000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	109000	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	71000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5579000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	22284000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-15762000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14404000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	49926000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-24000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-40000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2178000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2392000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19943000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-25410000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13346000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-15622000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-5995000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-4638000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-6917000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-2370000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-19920000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-4862000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2152000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-4416000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-4910000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-16340000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20974000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25925000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23076000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5342000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3614000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	331000	USD
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2013	us-gaap	Operating Expenses OperatingExpenses	20979000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	35037000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	41369000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-20964000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4645000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8522000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8022000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2345000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-23534000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4572000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2265000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4877000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4957000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-16671000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	27693000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4310000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4386000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4260000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4572000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4890000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5275000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1000000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2500000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4900000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1036000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	464000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-71000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	71000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	210000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	160000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-101000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-35000	USD
CY2014Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	300000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1450000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8200000	USD
CY2014Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37500000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	829000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2427000	USD
CY2013	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1263000	USD
CY2014	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
CY2015	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5352000	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6005000	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6736000	USD
CY2013	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	14438000	USD
CY2014	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	49934000	USD
CY2015	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7289000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9687000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2892000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4049000	USD
CY2015Q4	us-gaap	Purchase Obligation PurchaseObligation	300000	USD
CY2015Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	300000	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	300000	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	600000	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	0	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	0	USD
CY2013	us-gaap	Repayments Of Debt RepaymentsOfDebt	34000	USD
CY2014	us-gaap	Repayments Of Debt RepaymentsOfDebt	8000	USD
CY2015	us-gaap	Repayments Of Debt RepaymentsOfDebt	35000	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2500000	USD
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15104000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21263000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18890000	USD
CY2014Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Inception To Date RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate	80	position
CY2014Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Inception To Date Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent	0.30
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	400000	USD
CY2013Q4	us-gaap	Restructuring Reserve RestructuringReserve	100000	USD
CY2014Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	28796000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	51168000	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	19000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	4432000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	9658000	USD
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	14706000	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	28796000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	10849000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	13590000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	11309000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	15420000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	51168000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5875000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13774000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22479000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	926000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	839000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2747000	USD
CY2014Q3	us-gaap	Share Price SharePrice	2.55
CY2013	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	USD
CY2014	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	965000	USD
CY2015	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2014	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	3150000	USD
CY2014Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	15784313	shares
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48409000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	3894000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	35641000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	22130000	USD
CY2013	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	0	USD
CY2014	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	0	USD
CY2015	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-5203000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1250000	shares
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1250000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3150000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	900000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-63200000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10700000	USD
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1081000	USD
CY2015Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	757000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3016000	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11642000	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23760000	shares
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vericel Corporation, a Michigan corporation, which was formerly known as Aastrom Biosciences, Inc. (the Company, Vericel, we, us or our), was incorporated in March 1989 and began employee-based operations in 1991. On May 30, 2014, Vericel completed the acquisition of certain assets and assumed certain liabilities of Sanofi, a French société anonyme (Sanofi), including all of the outstanding equity interests of Genzyme Biosurgery ApS (Genzyme Denmark or the Danish subsidiary) (now known as Vericel Denmark ApS), a wholly-owned subsidiary of Sanofi, and over </font><font style="font-family:inherit;font-size:10pt;">250</font><font style="font-family:inherit;font-size:10pt;"> patent applications of Sanofi and certain of its subsidiaries for purposes of acquiring the portion of the cell therapy and regenerative medicine business (the CTRM Business), which researches, develops, manufactures, markets and sells the Carticel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, MACI™, and Epicel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> products. The Company is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products as well as developmental stage product candidates and the Company’s goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs.</font></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates its business primarily in the U.S. in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reportable segment — the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.</font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Successful future operations are subject to several technical hurdles and risk factors, including satisfactory product development, timely initiation and completion of clinical trials, regulatory approval and market acceptance of the Company’s products.</font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-012668-index-headers.html	Edgar Link	pending
0001628280-16-012668-index.html	Edgar Link	pending
0001628280-16-012668.txt	Edgar Link	pending
0001628280-16-012668-xbrl.zip	Edgar Link	pending
addtlexhibitf2005originallea.gif	Edgar Link	pending
astm-20151231.xml	Edgar Link	completed
astm-20151231.xsd	Edgar Link	pending
astm-20151231_cal.xml	Edgar Link	unprocessable
astm-20151231_def.xml	Edgar Link	unprocessable
astm-20151231_lab.xml	Edgar Link	unprocessable
astm-20151231_pre.xml	Edgar Link	unprocessable
businesspic2.jpg	Edgar Link	pending
depictionofpremise2005thirda.gif	Edgar Link	pending
ex1046transitionservicesas.htm	Edgar Link	pending
ex1047transitionsupplyasam.htm	Edgar Link	pending
ex1057vericel-cambridgelea.htm	Edgar Link	pending
ex1058vericel-cambridgelea.htm	Edgar Link	pending
ex1063dominos-vericellease.htm	Edgar Link	pending
ex211subsidiariesofregistr.htm	Edgar Link	pending
ex231consentofregisteredin.htm	Edgar Link	pending
ex31110k2015.htm	Edgar Link	pending
ex31210k2015.htm	Edgar Link	pending
ex32110k2015.htm	Edgar Link	pending
ex37stonepine-vericelxbloc.htm	Edgar Link	pending
exf2008leasea01.gif	Edgar Link	pending
exhibitf2005originallease.gif	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockperformancegrapha01.gif	Edgar Link	pending
vcel12-31x201510k.htm	Edgar Link	pending
vcelportfolio10mar2016.gif	Edgar Link	pending
vericelcambridgelease_image1.gif	Edgar Link	pending
vericelcambridgelease_image2.gif	Edgar Link	pending
vericelcambridgelease_image3.gif	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCEL
Vericel Corp Stock $vcel

2016 Q1 Form 10-K Financial Statement

#000162828016012668 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCEL Vericel Corp Stock $vcel

2016 Q1 Form 10-K Financial Statement

#000162828016012668 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCEL
Vericel Corp Stock $vcel